MDM2 and heart sarcoma: Nevertheless, understanding its molecular characteristics is important for understanding the unique biology of IS and may assist in the use of molecularly targeted agents (1).Chen et al.’s preliminary investigation of 70 primary cardiac sarcomas after molecular analysis revealed potentially actionable aberrations, including MDM2 and PDGFRA amplification.